Tenet Healthcare Corporation Revenue & Financials

Tenet's fiscal 2024 net income of $1.12 billion on $20.33 billion in revenue is a number that would have been almost inconceivable to anyone watching the company in 2006, when a $900 million fraud settlement was consuming cash and management attention simultaneously. The net margin of approximately 5.5% is thin by absolute standards but represents a genuine transformation from the near-insolvency of earlier decades. The USPI ambulatory surgery segment generated $550 million in adjusted EBITDA in fiscal 2024, with same-facility revenue growth of 6.5%. Orthopedics and gastroenterology drove the volume gains — high-acuity procedures that generate better economics than the commodity outpatient visits that fill schedule time but contribute little margin. Ambulatory surgery centers carry inherently better cost structures than acute care hospitals; lower overhead, no emergency department cross-subsidy requirements, and more predictable patient populations. The hospital segment's improvement to 12.8% adjusted EBITDA margin came almost entirely from labor cost management. Contract labor represented a massive expense at the 2022 peak — hospitals across the industry were paying travel nurses three to four times the rates of permanent staff. Tenet cut that dependency by 45% over two years. The fixed cost of training and retaining permanent nurses is high, but it is cheaper and more predictable than the contract market at its worst. The $13 billion market capitalization against $20.33 billion in revenue prices Tenet at roughly 0.64x revenue — a deep discount to the multiples that pure outpatient or technology-adjacent health services companies command. The debt reduction from more than $4 billion since 2020 continues to improve the credit profile, and an investment-grade rating would materially reduce interest expense, adding directly to net income without requiring any operational improvement.